Seed Oils, Inflammation and the Difference Between Chemistry and Clinical Evidence

The claim that “seed oils are toxic” is persuasive because it begins with facts that are easy to verify. Polyunsaturated fatty acids contain multiple double bonds and are therefore more susceptible to oxidation than saturated fats. Linoleic acid is an omega-6 fatty acid. Arachidonic acid participates in inflammatory signalling. Repeated high-temperature heating degrades cooking oils.

None of those statements is controversial.

The controversy begins with the next step: treating those observations as sufficient evidence that ordinary consumption of common vegetable oils causes chronic inflammation, obesity, diabetes or cardiovascular disease.

That step requires human outcome data. Chemistry can generate a hypothesis. It cannot finish the argument.

“Seed oil” is an imprecise exposure

The category itself already creates problems. Soybean, sunflower, corn, safflower, sesame, grapeseed and rapeseed oils differ materially in fatty-acid composition. High-oleic variants differ from conventional ones. Processing, storage, antioxidant content, heating temperature and reuse also change the exposure.

The phrase seed oils therefore combines multiple substances and cooking conditions under one rhetorical label.

This matters because claims that appear to concern one ingredient often mix evidence from very different contexts: fresh oil used in home cooking, industrial frying, repeatedly heated restaurant oil and ultra-processed foods containing refined oils. Those are not interchangeable exposures.

A serious causal claim needs to specify which oil, at what dose, under what thermal conditions, and compared with what alternative fat.

Linoleic acid and inflammation

The most common biological argument is that linoleic acid increases arachidonic acid, which then increases inflammatory mediators.

This pathway is real but incomplete.

Human fatty-acid metabolism is regulated, and conversion of dietary linoleic acid to arachidonic acid is limited. Arachidonic-acid-derived mediators are also not uniformly pro-inflammatory, and downstream signalling depends on tissue, enzyme activity and physiological context.

More importantly, randomized human trials have directly tested the inflammatory prediction.

A systematic review by Johnson and Fritsche found virtually no evidence that increasing dietary linoleic acid raises common markers of chronic inflammation in healthy adults. A later meta-analysis of 30 randomized trials likewise found no significant overall effect on CRP, TNF-α, IL-6 and several related biomarkers.

These trials do not prove that every possible dose in every population is harmless. They do show that the broad claim “omega-6 is inflammatory” is not supported by the human intervention evidence commonly used to test it.

This is an important distinction in nutrition science: a biochemical pathway can exist without producing the clinically assumed effect at realistic dietary exposures.

Cardiovascular disease depends on the comparator

Dietary-fat arguments become especially misleading when the replacement nutrient is omitted.

Replacing saturated fat with polyunsaturated fat is not the same intervention as adding oil to an energy-surplus diet. Replacing butter with canola oil is not the same as replacing vegetables with deep-fried snacks.

The comparator changes the question.

Prospective cohort meta-analyses have generally associated higher linoleic-acid intake with lower coronary risk, particularly when it replaces saturated fat. Biomarker studies across multiple cohorts have also found higher tissue or circulating linoleic acid associated with lower cardiovascular-event risk.

This is consistent with controlled feeding evidence showing that replacing saturated fat with unsaturated fat generally lowers LDL cholesterol.

That does not mean every vegetable oil has an identical health profile, nor that unlimited oil consumption is beneficial. It means the blanket claim that linoleic-acid-rich oils are cardiotoxic is inconsistent with a substantial body of human evidence.

WHO guidance reflects this broader evidence base by recommending replacement of saturated fats with unsaturated fats, including polyunsaturated fats.

Historical diet-heart trials deserve discussion, not erasure

Critics of linoleic acid often cite reanalyses of the Sydney Diet Heart Study and the Minnesota Coronary Experiment.

Those trials matter because they complicate any simplistic claim that increasing linoleic acid must always improve outcomes. The recovered Sydney data reported higher mortality in men assigned to a linoleic-acid intervention after coronary disease, while the Minnesota reanalysis found cholesterol lowering without the expected mortality benefit.

Ignoring those trials would be selective.

Treating them as decisive proof that seed oils are toxic would also be selective.

Both studies were conducted decades ago under food conditions that differ from modern diets. Some intervention fats contained trans fats, now recognised as harmful. Adherence, institutional settings, incomplete historical records and low omega-3 exposure complicate interpretation.

The correct scientific response is therefore not to choose the historical trial that best fits a preferred narrative. It is to integrate it with the broader evidence and preserve the uncertainty it introduces.

Repeated heating is a different problem

One of the strongest legitimate concerns in the seed-oil debate concerns repeated high-temperature heating.

Polyunsaturated fats are vulnerable to oxidative degradation. Repeated frying can increase aldehydes, peroxides and polar compounds. Experimental studies show clear chemical deterioration with repeated heating.

But evidence about repeatedly degraded frying oil cannot automatically be generalised to fresh oil used once in ordinary cooking.

The distinction is analogous to comparing fresh food with the same food after repeated thermal abuse. The substance has changed.

This is why statements such as “vegetable oil oxidises when heated, therefore cooking with it is toxic” are too broad. Temperature, duration, number of heating cycles and fatty-acid profile all matter.

A small 2026 randomized crossover trial comparing repeatedly heated with unheated oil altered postprandial triglyceride responses but did not demonstrate acute impairment in the vascular outcomes measured. That study is far from sufficient to settle long-term risk, but it illustrates why chemical degradation and clinical harm must still be connected empirically rather than assumed.

The sensible conclusion is narrower: repeatedly reusing degraded frying oil is a different and less desirable exposure than normal culinary use.

Ultra-processed foods do not identify the guilty ingredient

The seed-oil narrative also benefits from a real association: many ultra-processed foods contain refined vegetable oils, and higher ultra-processed-food intake is associated with adverse health outcomes.

But ultra-processed foods differ from minimally processed foods in many correlated ways: energy density, fibre, sodium, texture, palatability, eating rate, refined carbohydrate content, portion size and food structure.

Attributing the entire association to one ingredient is therefore a confounding problem.

A person who “eliminates seed oils” may simultaneously stop eating chips, biscuits, commercial sauces, fried takeaway foods and many packaged snacks. Their energy intake may fall, protein may rise, meals may become more structured and home cooking may increase.

If health improves, the improvement is real. The intervention, however, changed far more than one fatty acid.

This is one of the central themes in online nutrition: a broad behavioural change is retrospectively assigned to the ingredient that best fits the narrative.

The omega-6:omega-3 ratio is a poor summary statistic

Another popular claim is that health depends on keeping the omega-6:omega-3 ratio below a particular number.

The ratio can be mathematically identical under very different absolute intakes. A diet with 2 units of omega-6 and 1 of omega-3 has the same ratio as a diet with 20 and 10.

That makes the ratio an incomplete descriptor of exposure.

Reviews from the UK Food Standards Agency and the OPTILIP programme argued that the ratio is less informative than considering absolute intakes, especially adequate omega-3 intake.

The idea of a single “ancestral” ratio also tends to ignore geographic and dietary heterogeneity. Human diets were never one fixed formula.

Ratios can be useful descriptive quantities. They become misleading when treated as physiological laws.

Stability is not the same as healthfulness

Animal fats are sometimes presented as inherently safer because saturated fats are chemically more stable under heat.

Chemical stability is relevant to oxidation. It is not a complete measure of long-term health effect.

A highly saturated fat may oxidise less readily under some cooking conditions while also raising LDL cholesterol more than an unsaturated alternative. These are different endpoints.

The correct question therefore depends on the exposure of interest. If the concern is repeated deep-frying stability, oxidation chemistry matters strongly. If the concern is long-term cardiovascular risk, lipid effects and clinical outcome evidence become central.

No single property of a fat determines every health effect.

What the evidence supports

The strongest current human evidence does not support the claim that ordinary dietary linoleic acid is intrinsically inflammatory. Prospective and biomarker studies generally do not support the claim that higher linoleic-acid exposure increases cardiovascular or diabetes risk, and major dietary guidelines continue to favour replacing saturated fat with unsaturated fat.

At the same time, repeated high-temperature reuse of cooking oils produces real chemical degradation and deserves separate consideration. Historical diet-heart trials also remind us that dietary-fat evidence is not perfectly uniform.

The appropriate conclusion is therefore neither “all seed oils are poison” nor “all vegetable oils are harmless under every condition”.

The better conclusion is methodological: dose, oil composition, cooking conditions, dietary context and replacement nutrient determine the question being answered.

Once those variables are specified, the debate becomes scientific rather than tribal.

---

References

1. Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. Journal of the Academy of Nutrition and Dietetics. 2012;112:1029–1041. https://pubmed.ncbi.nlm.nih.gov/22889633/

2. Su H, Liu R, Chang M, Huang J, Wang X. Dietary linoleic acid intake and blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. 2017. https://pubmed.ncbi.nlm.nih.gov/28752873/

3. Innes JK, Calder PC. Omega-6 fatty acids and inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2018. https://pubmed.ncbi.nlm.nih.gov/29610056/

4. Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130:1568–1578. https://pubmed.ncbi.nlm.nih.gov/25161045/

5. Marklund M, Wu JHY, Imamura F, et al. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality. Circulation. 2019. https://pubmed.ncbi.nlm.nih.gov/30971107/

6. Mousavi SM, et al. Dietary intake of linoleic acid, its concentrations, and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Diabetes Care. 2021. https://pubmed.ncbi.nlm.nih.gov/34417277/

7. Ramsden CE, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study. BMJ. 2013. https://pubmed.ncbi.nlm.nih.gov/23386268/

8. Ramsden CE, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment. BMJ. 2016. https://pubmed.ncbi.nlm.nih.gov/27071971/

9. Stanley JC, et al. UK Food Standards Agency Workshop Report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. British Journal of Nutrition. 2007. https://pubmed.ncbi.nlm.nih.gov/18039412/

10. Jaarin K, et al. Heated vegetable oils and cardiovascular disease risk factors. Vascular Pharmacology. 2014. https://pubmed.ncbi.nlm.nih.gov/24632108/

11. Lane MM, et al. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ. 2024. https://pubmed.ncbi.nlm.nih.gov/38418082/

12. World Health Organization. Saturated fatty acid and trans-fatty acid intake for adults and children: WHO guideline. 2023. https://www.who.int/publications/i/item/9789240073630

---

This article discusses population-level nutrition evidence. It is not an individual dietary prescription.